Without a companion program, its possible to end up with sarcopenic obesity and a higher body fat composition than before starting the meds up to 40% of weight loss can be muscle
These follow-on patents form a systematic attempt to add barriers of entry for generic competitors, with the intention of extending Novo Nordisks market monopoly for as long as possible when the main compound patent on the underlying active ingredient, semaglutide, expires
Brehm A, Pfeiler G, Pacini G, Vierhapper H, Roden M
At Skin Artisans, your GLP-1 medical weight loss program is completely personalized based on your current weight and overseen by our Hormone Optimization and Medical Weight Loss Specialist, Rachel Snyder, APRN, CNP, ensuring that your unique needs are met